- Center on Health Equity & Access
- Clinical
- Health Care Cost
- Health Care Delivery
- Insurance
- Policy
- Technology
- Value-Based Care
Dr Jeff White: Best Practices for Preventing Opioid Misuse
Jeff White, PharmD, MS, staff vice president, Anthem, outlines best practices for preventing opioid misuse.
Jeff White, PharmD, MS, staff vice president, Anthem, outlines best practices for preventing opioid misuse.
Transcript
What are some best practices for opioid management in order to prevent misuse?
Best practices include hard policies to help ensure clinically appropriate use. For example, 7-day supply limit for individuals newly starting on a short-acting opioid. Also, prior authorization for individuals newly starting on a long-acting opioid therapy. Also, medication assisted therapy, such as buprenorphine and naltrexone, should be made available, and also making available the rescue antidote called naloxone for those who are high risk for overdose.
Additional best practices include monitoring and understanding use patterns by prescribers and patients and developing and implementing programs that help guide clinically appropriate therapy.
Hope on the Horizon for Underserved Patients With Multiple Myeloma: Joseph Mikhael, MD
August 12th 2025Explore the disparities in multiple myeloma treatment and how new initiatives aim to improve clinical trial participation among underrepresented patients during a conversation with Joseph Mikhael, MD, MEd, FRCPC, FACP, FASCO, chief medical officer of the International Myeloma Foundation.
Listen
Accessing pediatric dermatology care is challenging due to a shortage of specialists and general dermatologists' reluctance to treat children, but increasing their comfort level with seeing children could help bridge the gap, explained Elizabeth Garcia Creighton, of University of Colorado School of Medicine.
Read More
IgE Mediation in Pediatric Atopic Dermatitis, Concurrent Immune Disorders: Amy Paller, MD
August 4th 2025Amy Paller, MD, pediatric dermatologist and clinical researcher at Northwestern Medicine's Feinberg School of Medicine, discussed the potential impact of reducing immunoglobulin E (IgE) levels in pediatric patients with atopic dermatitis.
Read More
